RxDoctor Payments Data

Sunil Vasireddi, MD

Cardiovascular Disease · Madison, WINPI 1629497722

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (51.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medtronic at 36.1% of the total. Reporting peaked in 2022 at $16,797 and has fallen 86.9% since, to $2,203 in 2025. Among cardiovascular disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,003in general payments, 2019–2025

Across 110 payments — averaging $327.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Biotronik Inc.$9K
  • Boston Scientific$8K
  • Abbott$6K
  • Biosense Webster, Inc.$427
  • Atricure, Inc.$90

What the payments were for

  • Grants$18,63552%
  • Travel & lodging$10,94130%
  • Food & beverage$5,00914%
  • Education$1,4184%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic15$12,981
Biotronik Inc.24$9,260
Boston Scientific2$7,500
Abbott65$5,746
Biosense Webster, Inc.3$427
Atricure, Inc.1$90

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,003 in reported general payments places this provider in the 95th percentile of 322 cardiovascular disease providers in Wisconsin.

See all cardiovascular disease providers in Wisconsin

Medicare billing

Part B allowed, 2024
$138,231
Medicare patients
891
Services billed
2,291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$35,493
Metoprolol Succinate56$1,434
Flecainide Acetate17$813
Amiodarone Hcl42$700
Pantoprazole Sodium20$100
Carvedilol14$95
Metoprolol Tartrate11$87

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →